Antheia Announces New Financing And Plans To Construct Pilot Plant Facility For Biomanufacturing
PRIVATEJun 22, 2022
Round Type
Funding Round
Menlo ParkInformation Technology
Description
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced $40 million in venture debt financing from Oxford Finance LLC and Silicon Valley Bank, alongside plans to construct a new pilot scale biomanufacturing facility. The financing will support Antheia's expansion with a 14,700 square-foot pilot plant located next to Antheia's headquarters in Menlo Park, CA. The new pilot plant will enable the company to significantly improve efficiency and support the scale up of its growing portfolio of products.
Who to call at Antheia, Inc., and when
A new round usually means Antheia, Inc. is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Antheia, Inc. raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Antheia, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Antheia, Inc.. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Antheia, Inc.
Location
1505 O'BRIEN DRIVE, SUITE B1
Menlo Park, California, United States
About
Antheia is unlocking the medicinal power of nature. Its synthetic biology platform surpasses the limits of conventional drug discovery and manufacturing through a novel approach to whole cell engineering reconstructing complex molecules in yeast to bring to market next generation plant inspired medicines. Antheia’s team of scientists and technologists is headquartered in Menlo Park, California. For more information, visit www.antheia.bio.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Antheia, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.